3.1200
-0.1300
(-4.00%)
At close: January 10 at 4:00:01 PM EST
3.2400
+0.12
+(3.85%)
After hours: January 10 at 6:37:04 PM EST
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 3 | 2 | 3 | 3 |
Avg. Estimate | -0.63 | -0.65 | -0.46 | -2.01 |
Low Estimate | -0.8 | -0.76 | -0.63 | -2.38 |
High Estimate | -0.52 | -0.54 | -0.34 | -1.42 |
Year Ago EPS | -0.72 | -0.84 | -4.2 | -0.46 |
Revenue Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 4 | 1 | 4 | 4 |
Avg. Estimate | 1M | -- | 1.05M | 2.45M |
Low Estimate | -- | -- | -- | -- |
High Estimate | 4M | -- | 4.07M | 9.81M |
Year Ago Sales | 1.81M | 9.3k | 2.81M | 1.05M |
Sales Growth (year/est) | -44.69% | -100.00% | -62.43% | 132.45% |
Earnings History
Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
---|---|---|---|---|
EPS Est. | -0.96 | -0.72 | -0.66 | -0.71 |
EPS Actual | -0.72 | -0.84 | -0.89 | -0.55 |
Difference | 0.24 | -0.12 | -0.23 | 0.16 |
Surprise % | 25.00% | -16.67% | -35.21% | 22.54% |
EPS Trend
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | -0.63 | -0.65 | -0.46 | -2.01 |
7 Days Ago | -0.57 | -0.14 | -0.2 | -1.95 |
30 Days Ago | -0.57 | -0.14 | -0.2 | -1.95 |
60 Days Ago | -0.57 | -0.14 | -0.2 | -1.95 |
90 Days Ago | -0.57 | -0.14 | -0.2 | -1.95 |
EPS Revisions
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | 1 | -- | 1 | 1 |
Up Last 30 Days | 1 | -- | 1 | 1 |
Down Last 7 Days | 1 | -- | -- | 1 |
Down Last 30 Days | 1 | -- | -- | 1 |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
DARE | 12.04% | 22.62% | 89.05% | -337.68% |
S&P 500 | 8.59% | 11.42% | 13.98% | 13.43% |
Upgrades & Downgrades
Reiterates | HC Wainwright & Co.: Buy to Buy | 12/17/2024 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 11/15/2024 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 10/24/2024 |
Maintains | Jones Trading: Buy to Buy | 8/16/2024 |
Downgrade | Maxim Group: Buy to Hold | 8/14/2024 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 5/15/2024 |
Related Tickers
XBIO Xenetic Biosciences, Inc.
3.8600
-4.22%
VTVT vTv Therapeutics Inc.
13.80
-2.06%
ALRN Aileron Therapeutics, Inc.
2.1100
+9.33%
CRIS Curis, Inc.
3.3900
-2.02%
PXMD PaxMedica, Inc.
0.0580
-10.77%
ACHV Achieve Life Sciences, Inc.
3.3800
-3.98%
RLMD Relmada Therapeutics, Inc.
0.4124
-8.76%
IRD Opus Genetics, Inc.
1.4200
-2.07%
COCP Cocrystal Pharma, Inc.
2.2100
-7.14%
TOVX Theriva Biologics, Inc.
1.4500
-1.36%